← Back to Search

Community-based Psychological Services for Mental Health (RECOUP-NY Trial)

N/A

Recruiting

Led By Brandon Kohrt, MD, PhD

Research Sponsored by George Washington University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 weeks after baseline assessment

Awards & highlights

RECOUP-NY Trial Summary

This trialstudies ways to improve mental health for minority & vulnerable groups during the pandemic, & the impact of mental health services on prevention behaviors, vaccinations & healthcare utilization.

Who is the study for?

This trial is for individuals in New York City who are experiencing depression, anxiety, or other psychological distress after SARS-CoV-2. Participants should have a certain score on a health questionnaire and be struggling with daily activities due to their mental state. People at acute suicide risk or without functional impairment cannot join.Check my eligibility

What is being tested?

The study tests 'Problem Management Plus', a mental health service, against the usual services provided. It aims to see if this can improve behaviors related to preventing SARS-CoV-2 spread, vaccination uptake, and safe healthcare use among minority and vulnerable groups.See study design

What are the potential side effects?

Since this trial involves psychological services rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort when discussing personal issues during therapy sessions.

RECOUP-NY Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 weeks after baseline assessment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 weeks after baseline assessment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks after baseline assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Psychological Outcome Profiles Questionnaire; Unabbreviated scale title "Psychological Outcome Profiles questionnaire"

Secondary outcome measures

Coronavirus disease of 2019 experiences and attitudes tool; Unabbreviated scale title "Coronavirus disease of 2019 experiences and attitudes tool"

Generalized Anxiety Disorder 7; Unabbreviated scale title "Generalized Anxiety Disorder 7"

Patient Health Questionnaire 9; Unabbreviated scale title "Patient Health Questionnaire 9"

+2 more

Other outcome measures

Intolerance of Uncertainty Scale-Short Form; Unabbreviated title "Intolerance of Uncertainty Scale-Short Form"

Reducing Tension Checklist, Unabbreviated title "Reducing Tension Checklist"

RECOUP-NY Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Problem Management PlusExperimental Treatment1 Intervention

Persons screening positive for depression will be offered Problem Management Plus delivered by community based organization staff.

Group II: Services as usualActive Control1 Intervention

Persons screening positive for depression will be referred from community-based organizations. The referrals will be made to mental health specialists who will provide care based on their standard of care.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Problem Management Plus

2018

N/A

~120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

George Washington UniversityLead Sponsor

243 Previous Clinical Trials

452,274 Total Patients Enrolled

13 Trials studying Depression

10,606 Patients Enrolled for Depression

The New SchoolOTHER

4 Previous Clinical Trials

381 Total Patients Enrolled

1 Trials studying Depression

45 Patients Enrolled for Depression

Duke UniversityOTHER

2,363 Previous Clinical Trials

3,419,006 Total Patients Enrolled

74 Trials studying Depression

32,856 Patients Enrolled for Depression

Media Library

Problem Management Plus Clinical Trial Eligibility Overview. Trial Name: NCT04913766 — N/A

Depression Research Study Groups: Services as usual, Problem Management Plus

Depression Clinical Trial 2023: Problem Management Plus Highlights & Side Effects. Trial Name: NCT04913766 — N/A

Problem Management Plus 2023 Treatment Timeline for Medical Study. Trial Name: NCT04913766 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to currently participate in this experiment?

"That is correct. The information posted on clinicaltrials.gov reveals that this research, which was initially published on November 7th 2022, is actively seeking participants. Approximately 1500 patients need to be enrolled from a single trial site."

Answered by AI

What is the total participant count of this clinical trial?

"Indeed, the documents on clinicaltrials.gov attest to this trial's ongoing recruitment efforts. Initially posted on November 7th 2022 and most recently updated on November 18th of that same year, the study is taking in 1500 participants at a single site."

Answered by AI